Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6727096 | 0.90 | MEN1 (0.37) | KDM4EL3MBTL1ALDH1A1GLAKMT2A | |
| Hydrochloric Acid SCHEMBL10435583 | 0.79 | CHRM1 (0.41) | KDM4E | |
| SCHEMBL7435203 | 0.71 | PARP1 (0.36) | AURKARPS6KB1KDM4EL3MBTL1ALDH1A1 | |
| SCHEMBL25374867 | 0.69 | — | — | |
| SCHEMBL17766590 | 0.64 | PARP1 (0.47) | KDM4EALDH1A1GAATRPA1 | |
| SCHEMBL7268507 | 0.63 | KDM4E (0.41) | KDM4EL3MBTL1ALDH1A1KMT2APOLB | |
| SCHEMBL6135290 | 0.61 | ATM (0.61) | AURKAKDM4EL3MBTL1ALDH1A1GLA | |
| SCHEMBL31022973 | 0.60 | AURKA (0.50) | AURKARPS6KB1KMT2APOLB | |
| SCHEMBL4893838 | 0.60 | PARP1 (0.30) | — | |
| SCHEMBL5760526 | 0.59 | PARP1 (0.39) | AURKARPS6KB1KDM4EALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | LI XIAOBING | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | GBA3, PSMB3, SEC61B | AURKA 3881/4885RPS6KB1 2007/4885KDM4E 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.